ACUTE GRAFT VERSUS HOST DISEASE GRADE II-IV

Clinical trials for ACUTE GRAFT VERSUS HOST DISEASE GRADE II-IV explained in plain language.

Never miss a new study

Get alerted when new ACUTE GRAFT VERSUS HOST DISEASE GRADE II-IV trials appear

Sign up with your email to follow new studies for ACUTE GRAFT VERSUS HOST DISEASE GRADE II-IV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Hope for transplant patients: new pill tested for Life-Threatening complication

Disease control Not yet recruiting

This study is testing the safety and effectiveness of an experimental oral medication called gimacabtinib for patients with severe acute graft-versus-host disease (GVHD). It is for adults who have had a stem cell transplant and whose GVHD did not improve or got worse after trying…

Matched conditions: ACUTE GRAFT VERSUS HOST DISEASE GRADE II-IV

Phase: PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control

Last updated Mar 31, 2026 12:10 UTC

ACUTE GRAFT VERSUS HOST DISEASE GRADE II-IV

Get alerted when new ACUTE GRAFT VERSUS HOST DISEASE GRADE II-IV trials appear

Hope for transplant patients: new pill tested for Life-Threatening complication